Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nico Gabriel

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
JAMA Network Open|January 4, 2023
Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare BeneficiariesZachary A Marcum, Nico Gabriel, Adam P Bress, et al.
JAMA Network Open|July 16, 2020
Evaluation of Frequency of Encounters With Primary Care Physicians vs Visits to Community Pharmacies Among Medicare BeneficiariesLucas A Berenbrok, Nico Gabriel, Kim C Coley, et al.
Pharmacoepidemiology and Drug Safety|February 19, 2021
Using machine learning to identify diabetes patients with canagliflozin prescriptions at high-risk of lower extremity amputation using real-world dataLanting Yang, Nico Gabriel, Inmaculada Hernandez, et al.
Journal of Managed Care & Specialty Pharmacy|October 25, 2022
COVID-19 and adherence to biologic therapies for psoriasis: An analysis of nationwide pharmacy claims dataMeiqi He, Laura K Ferris, Nico Gabriel, et al.
Diabetes Research and Clinical Practice|March 29, 2022
Association of formulary restrictions and initiation of an SGLT2i or GLP1-RA among Medicare beneficiaries with type 2 diabetesJing Luo, Nico Gabriel, Mary Korytkowski, et al.
Journal of Managed Care & Specialty Pharmacy|March 28, 2025
Limited utility of price transparency data for drugsYuvraj Pathak, Elvira Makk Frid, Nico Gabriel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 3, 2025
Integrating Price Benchmarks and Comparative Clinical Effectiveness to Predict Initial Price Offers for Medicare Drug Price Negotiation (Initial Price Applicability Year 2027)Kevin H Li, Emma M Cousin, Nico Gabriel, et al.
JAMA Health Forum|February 28, 2025
Overpayment for Generic Drugs Under Medicare Part DInmaculada Hernandez, Nico Gabriel, Yuvraj Pathak, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2026
Spending Impact of the First Ten Drugs Selected for Medicare Drug Price Negotiation in the USYunjoo K Jeon, Ryan N Hansen, Nico Gabriel, et al.
Plos Medicine|July 28, 2022
Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional studyInmaculada Hernandez, Sean Dickson, Shangbin Tang, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
JAMA Network Open|January 4, 2023
Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare BeneficiariesZachary A Marcum, Nico Gabriel, Adam P Bress, et al.
JAMA Network Open|July 16, 2020
Evaluation of Frequency of Encounters With Primary Care Physicians vs Visits to Community Pharmacies Among Medicare BeneficiariesLucas A Berenbrok, Nico Gabriel, Kim C Coley, et al.
Pharmacoepidemiology and Drug Safety|February 19, 2021
Using machine learning to identify diabetes patients with canagliflozin prescriptions at high-risk of lower extremity amputation using real-world dataLanting Yang, Nico Gabriel, Inmaculada Hernandez, et al.
Journal of Managed Care & Specialty Pharmacy|October 25, 2022
COVID-19 and adherence to biologic therapies for psoriasis: An analysis of nationwide pharmacy claims dataMeiqi He, Laura K Ferris, Nico Gabriel, et al.
Diabetes Research and Clinical Practice|March 29, 2022
Association of formulary restrictions and initiation of an SGLT2i or GLP1-RA among Medicare beneficiaries with type 2 diabetesJing Luo, Nico Gabriel, Mary Korytkowski, et al.
Journal of Managed Care & Specialty Pharmacy|March 28, 2025
Limited utility of price transparency data for drugsYuvraj Pathak, Elvira Makk Frid, Nico Gabriel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 3, 2025
Integrating Price Benchmarks and Comparative Clinical Effectiveness to Predict Initial Price Offers for Medicare Drug Price Negotiation (Initial Price Applicability Year 2027)Kevin H Li, Emma M Cousin, Nico Gabriel, et al.
JAMA Health Forum|February 28, 2025
Overpayment for Generic Drugs Under Medicare Part DInmaculada Hernandez, Nico Gabriel, Yuvraj Pathak, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2026
Spending Impact of the First Ten Drugs Selected for Medicare Drug Price Negotiation in the USYunjoo K Jeon, Ryan N Hansen, Nico Gabriel, et al.
Plos Medicine|July 28, 2022
Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional studyInmaculada Hernandez, Sean Dickson, Shangbin Tang, et al.
Pageof 5